Related Experiment Videos
A ten-year, single institution experience with laparoscopic splenectomy
Robert L Bell1, Kate E Reinhardt, Eugene Cho
1Section of Surgical Endoscopy and Laparoscopy, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA. robert.bell@yale.edu
Summary
Laparoscopic splenectomy (LS) is a safe spleen treatment. Over 10 years, spleen size increased, but blood loss and conversion rates significantly decreased.
Area of Science:
- Minimally Invasive Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Laparoscopic splenectomy (LS) is the standard of care for specific spleen diseases.
- While safety and feasibility are documented, long-term outcome data for LS are limited.
- This study presents a 10-year institutional experience with LS to analyze procedural outcome trends.
Purpose of the Study:
- To evaluate long-term procedural outcomes of laparoscopic splenectomy.
- To identify trends in safety and efficacy over a decade of practice.
- To compare early versus later patient cohorts undergoing LS.
Main Methods:
- A 10-year prospective study (1992-2001) of 109 unselected patients undergoing LS for hematological diseases.
- Patients were divided into two cohorts: the first 55 (Group I) and the subsequent 54 (Group II).
- Data were collected via a longitudinal database, medical records, and patient interviews, analyzed using the unpaired Student t test.
Main Results:
- Operative time was similar between groups (151 min vs. 159 min).
- Estimated blood loss significantly decreased from 544 mL in Group I to 308 mL in Group II (P=0.015).
- Conversion rate to open surgery decreased from 13% in Group I to 2% in Group II (P<0.05).
- Mean spleen specimen weight increased significantly from 288 g in Group I to 512 g in Group II (P=0.03).
- Morbidity rates were comparable (13% vs. 9%).
Conclusions:
- Laparoscopic splenectomy is a safe and effective procedure for diverse indications over a 10-year period.
- Despite increasing spleen size, significant improvements in blood loss and conversion rates were achieved.
- LS demonstrates favorable long-term outcomes and evolving procedural efficiency.